Elevated leptin, under insulin resistance and hyperinsulinaemia, further reinforces this oncogenic landscape by activating mitogenic, anti-apoptotic, and pro-angiogenic pathways (JAK2-STAT3 and PI3K-Akt) and maintaining cancer stem-like phenotypes in many tumour types. This evidence concerns the gene LEP and cancer.